1-2 of 2
R. Foà, MD
Close
Sort by
Journal Articles

A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.

B. Bruno, MD, M. Rotta, MD, F. Patriarca, MD, D. Mattei, MD, B. Allione, MD, F. Carnevale-Schianca, MD, A. Rambaldi, MD, M. Casini, MD, V. Montefusco, MD, M. Parma, MD, P. Bavaro, MD, F. Onida, MD, A. Busca, MD, L. Castagna, MD, M.P. Iori, MD, D. Maloney, MD, B. Sandmaier, MD, F. Benedetti, MD, N. Mordini, MD, L. Giaccone, MD, R. Sorasio, MD, F. Fiore, MD, A. Filippi, MD, A. Palumbo, MD, M. Aglietta, MD, A. Levis, MD, R. Foà, MD, P. Di Bartolomeo, MD, E. Pogliani, MD, G. Lambertenghi-Deliliers, MD, M. Falda, MD, M. Petrini, MD, P. Corradini, MD, R. Fanin, MD, U. Ricardi, MD, R. Storb, MD, I. Baldi, B.Sc, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 3026.
https://doi.org/10.1182/blood.V110.11.3026.3026
Published: 2007
Journal Articles

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PhD, Fabrizio Pane, MD, M. Vignetti, MD, P. Fazi, MD, S. Iacobelli, PhD, G. Meloni, MD, A. Vitale, MD, V. Martini, MD, G. Martinelli, MD, F. Di Raimondo, MD, M. Bonifacio, MD, F. Fabbiano, MD, G. Saglio, MD, M. Baccarani, MD, R. Foà, MD, F. Mandelli, MD
Journal: Blood
Blood (2006) 108 (11): 638.
https://doi.org/10.1182/blood.V108.11.638.638
Published: 2006